GPT and Increased total eosinophil count: A guidance for the management of suspected DILI has recommended consideration be given to stopping the suspected drug in any of the following situations: when ALT exceeding 8X the upper limit of normal (ULN); ALT exceeding 5XULN for more than 2 weeks; ALT exceeding 3XULN with total bilirubin > 2XULN or international normalized ratio (INR) > 1.5 (Hy’s Law criteria [9–12]]; ALT exceeding 3XULN with symptoms including fatigue, nausea, vomiting, right upper quadrant pain or tenderness, fever, rash, or eosinophilia [13].